CCL11



CCL11

H1HH1P2PP2G3GG3S4SS4I5II5P6PP6T7TT7S8SS8C9CC9C10CC10F11FF11I12II12M13MM13T14TT14S15SS15K16KK16K17KK17I18II18P19PP19N20NN20T21TT21L22LL22L23LL23K24KK24S25SS25Y26YY26K27KK27R28RR28I29II29T30TT30N31NN31N32NN32R33RR33C34CC34T35TT35L36LL36K37KK37A38AA38I39II39V40VV40F41FF41K42KK42T43TT43R44RR44L45LL45G46GG46K47KK47... and 27 more residue(s)...... and 27 more residue(s)

SMILES None
InChIKey None
Sequence HPGSIPTSCCFIMTSKKIPNTLLKSYKRITNNRCTLKAIVFKTRLGKEICADPKKKWVQDATKHLDQKLQTPKP

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL11

H1HH1P2PP2G3GG3S4SS4I5II5P6PP6T7TT7S8SS8C9CC9C10CC10F11FF11I12II12M13MM13T14TT14S15SS15K16KK16K17KK17I18II18P19PP19N20NN20T21TT21L22LL22L23LL23K24KK24S25SS25Y26YY26K27KK27R28RR28I29II29T30TT30N31NN31N32NN32R33RR33C34CC34T35TT35L36LL36K37KK37A38AA38I39II39V40VV40F41FF41K42KK42T43TT43R44RR44L45LL45G46GG46K47KK47... and 27 more residue(s)...... and 27 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.